Online ISSN: 2515-8260

Keywords : Co-morbidities

To evaluate cardiac co-morbidities in patients with newly diagnosed type 2 diabetes mellitus using 2d echocardiography

Aniket Avhad, Achyut Kannawar, Dany John, Vijaysinh Patil, Ramesh Kawade

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 4729-4734

Aim: To evaluate cardiac co-morbidities in patients with newly diagnosed type 2 diabetes mellitus using 2d echocardiography.
Method and material: This research comprised 100 newly diagnosed type 2 diabetes mellites individuals who were clinically asymptomatic, had blood pressure of 130/80mmHg, and had a normal ECG. All patients underwent FBS, PPBS, Renal function tests, including electrolytes, Glycosylated haemoglobin (HbA1c), urine routine and microscopy, ECG, Fundoscopy, Chest x-ray, and Echocardiography.
Results: In the current research, 100 asymptomatic type 2 diabetes mellitus patients received 2-D echocardiography, with men (75%) outnumbering women (25%). The most prevalent age groups were 45-55 years and 55-65 years (30% apiece), with under 45 years (22%). Diastolic dysfunction was detected on 2-D echocardiography in 22 individuals (22%). Diastolic dysfunction of grades I, II, and III was seen in 12%, 7%, and 3% of patients, respectively. In present study, reduced early mitral inflow velocity was noted in 10 cases (10%) and mitral annular early diastolic velocity was noted in 19 cases (19%). We discovered that when HbA1c levels rise, so does the degree of left ventricular diastolic dysfunction; this difference was statistically significant (Chi-square test, p value 0.001). Three cases with grade 3 diastolic dysfunction had HbA1c >9.5, two cases with HbA1c >9.5 had grade 2 diastolic dysfunction, and six cases with HbA1c >9.5 had grade 1 diastolic dysfunction, all of which had LVDD.
Conclusion: Screening for cardiovascular abnormalities by 2D Echo is indicated in all newly diagnosed type 2 diabetes melites patients, with or without cardiovascular symptoms, so that early measures may be done to avoid further development of symptomatic cardiovascular abnormalities.

The co-morbidities associated with protein energy malnutrition in children

Dr.Arun Katti,Dr.Keludeppa Talawar,Dr.Manoj Kadlimatti,Dr.Vinaya kumar

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 2153-2157

Malnutrition in children continues to dominate the health scenario in India and other developing countries especially in South East Asia. More than one fourth of under 5 children worldwide (150 million) are under weight. 27% (182 million) are stunted, while 10% are wasted. Of all children under the age of five years in developing countries about 31% are under weight, 38% have stunted growth and 9% have wasting. All Children of age 6 months to 60 months admitted to the Paediatric ward, fulfilling the inclusion criteria, during the study period, was included in the study. In our study, ARI with 44.08% is the most common co-morbidity affected, followed by acute gastroenteritis with 27.96%, followed by sepsis with 8.53% followed by UTI with 8.06%, followed by meningitis with 4.27%, followed by malaria with 2.84%, Tuberculosis with 2.84% and skin infection with 1.42%.